DNA double-strand break repair activities in mammary epithelial cells - Influence of endogenous p53 variants

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1260-1268

  Keimling, Marlen ^a   Wiesmüller, Lisa ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER SUSCEPTIBILITY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; GENE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE LOSS; GENE MUTATION; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN VARIANT; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; MAMMARY GLANDS, HUMAN; MUTATION; PROTEIN ISOFORMS; RECOMBINATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67650150998     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp117     Document Type: Article

References (51)

1. Lacroix,N. et al. (2006) p53 and breast cancer, an update. Endocr. Relat. Cancer, 13, 293-325.
2. Walsh,T. et al. (2007) Ten genes for inherited breast cancer. Cancer Cell, 11, 103-105.
3. Ralhan,R. et al. (2007) Links between DNA double strand break repair and breast cancer: Accumulating evidence from both familial and nonfamilial cases. Cancer Lett., 248, 1-17.
4. Malkin,D. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
5. Concin,N. et al. (2003) Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res. Treat., 79, 37-46.
6. Wasielewski,M. et al. (2006) Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res. Treat., 99, 97-101.
7. Saal,L.H. et al. (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat. Genet., 40, 102-107.
8. Campomenosi,P. et al. (2001) p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene, 20, 3573-3579.
9. Oberosler,P. et al. (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J., 12, 2389-2396.
10. Bakalkin,G. et al. (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl Acad. Sci. USA, 91, 413-417.
11. Lee,S. et al. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81, 1013-1020.
12. Lee,S. et al. (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem., 272, 7532-7539.
13. Dudenhöffer,C. et al. (1998) Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol., 18, 5332-5342.
14. Mummenbrauer,T. et al. (1996) p53 Protein exhibits 3′-to-5′ exonuclease activity. Cell, 85, 1089-1099.
15. Süsse,S. et al. (2000) Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene, 19, 4500-4512.
16. Skalski,V. et al. (2000) Substrate specificity of the p53-associated 3′-5′ exonuclease. Oncogene, 19, 3321-3329.
17. Stürzbecher,H.W. et al. (1996) p53 is linked directly to homologous recombination processes via Rad51/RecA protein interaction. EMBO J., 15, 1992-2002.
18. Buchhop,S. et al. (1997) Interaction of p53 with the human Rad51 protein. Nucleic Acids Res., 25, 3868-3874.
19. Sengupta,S. et al. (2003) BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J., 22, 1210-1222.
20. Linke,S.P. et al. (2003) p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res., 63 2596-2605.
21. Romanova,L.Y. et al. (2004) The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene, 23, 9025-9033.
22. Ouchi,T. et al. (1998) BRCA1 regulates p53-dependent gene expression. Proc. Natl Acad. Sci. USA, 95, 2302-2306.
23. Zhang,H. et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16, 1713-1721.
24. Marmorstein,L.Y. et al. (1998) The BRCA2 gene product functionally interacts with p53 and Rad51. Proc. Natl Acad. Sci. USA, 95, 13869-13874.
25. Yoon,D. et al. (2004) p53 inhibits strand exchange and replication fork regression promoted by human Rad51. J. Mol. Biol., 336, 639-654.
26. Bertrand,P. et al. (2004) p53's double life: transactivation-independent repression of homologous recombination. Trends Genet., 20, 235-243.
27. Sengupta,S. et al. (2005) p53: Traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol., 6, 44-55.
28. Gatz,S.A. et al. (2006) p53 in recombination and repair. Cell Death Differ., 13, 1003-1016.
29. Akyüz,N. et al. (2002) DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol. Cell. Biol., 22 6306-6317.
30. Dahm-Daphi,J. et al. (2005) Nonhomologous end-joining of site-specific but not of radiation-induced DNA double-strand breaks is reduced in the presence of wild-type p53. Oncogene, 24, 1663-1672.
31. Yun,S. et al. (2004) Discriminatory suppression of homologous recombination by p53. Nucleic Acids Res., 32, 6479-6489.
32. Mérel,P. et al. (2002) Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines. Oncogene, 21, 5654-5659.
33. Keimling,M. et al. (2008) A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens. Int. J. Cancer, 123, 730-736.
34. Restle,A. et al. (2008) Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants. Nucleic Acids Res., 36, 5362-5375.
35. Rubnitz,J. et al. (1984) The minimum amount of homology required for homologous recombination in mammalian cells. Mol. Cell. Biol., 4, 2253-2258.
36. Siehler,S.Y. et al. (2009) Human MutL-complexes monitor homologous recombination independently of mismatch repair. DNA Repair (Amst.) 8, 242-252.
37. Brummelkamp,T.R. et al. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553.
38. Restle,A. et al. (2005) Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination. Oncogene, 24, 4380-4387.
39. Arias-Lopez,C. et al. (2006) p53 modulates homologous recombination by transcriptional regulation of the Rad51 gene. EMBO Rep., 7, 219-224.
40. Rothkamm,K. et al. (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell. Biol., 23 5706-5715.
41. Stark,J. M. et al. (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol. Cell. Biol., 24, 9305-9316.
42. Baldeyron,C. et al. (2002) A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene, 21, 1401-1410.
43. Saintipy,Y. et al. (1999) Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene, 18, 3553-3563.
44. Kachhap,S.K. et al. (2001) Reduced expression of the BRCA1 gene and increased chromosomal instability in MCF-7 cell line. Cell Biol. Int., 25, 547-551.
45. Müller,P. et al. (2008) Chaperone-dependent stabilization and degradation of p53 mutants. Oncogene, 27, 3371-3383.
46. Okorokov,A.L. et al. (2002) Effect of wild-type, S15D and R175H p53 proteins on DNA end joining in vitro: Potential mechanism of DNA double-strand break repair modulation. Carcinogenesis, 23 549-557.
47. Dudenhöffer,C. et al. (1999) Dissociation of the recombination control and the sequence-specific transactivation function of p53. Oncogene, 18, 5773-5784.
48. Atz,J. et al. (2000) Function, oligomerization, and conformation of tumor-associated p53 proteins with mutated C-terminus. J. Cell. Biochem., 76, 572-584.
49. Shen,W.H. et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell, 128, 157-170.
50. Holstege,H. et al. (2009) High incidence of protein-truncating TP53 mutations in BRICA1-related breast cancer. Cancer Res., 69 3625-3633.
51. Lu,X. et al. (2003) Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat. Res., 522, 69-83.